Page results
-
UCLH is to trial a COVID-19 vaccine developed by Imperial College London.
-
Research published in the latest issue of the Journal of Medical Genetics concludes that regularly monitoring women who carry BRCA gene alterations does provide some benefits.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
UCLH will play a vital role in a new respiratory virus study.
-
Today is the 72 anniversary of the NHS – and it is dedicated to our amazing staff.
-
UCLH is to host to a new collaboration researching patient safety, after being awarded £3million in funding.
-
It’s a clean sweep for our nominees at this year’s RCN Nursing Awards. Congratulations to winners Jo Hargroves, Robert Vicente and Susie Lagrata!
-
UCLH will be part of a first-of-its kind clinical trial, led by scientists at UCL, that will evaluate the use of ‘real time’ viral genomic data to reduce the spread of COVID-19 within hospitals.
-
UCLH chair Baroness Julia Neuberger has today announced that Professor Marcel Levi will be stepping down from his role as UCLH chief executive on 31 March 2021.
-
As a mark of respect for the funeral of Her Majesty The Queen on Monday 19 September, we are postponing our Annual Members’ Meeting, which was scheduled for this date.
File results
-
FOI/2023/0568 - Adverse reactions to the Astra Zeneca Covid vaccine
-
FOI/2023/0603 - Treatment of dermatological conditions
-
FOI/2023/0606 - Carbon emissions 2019/20 to 2022/23
-
FOI/2023/0632 - Whittington Health & UCLH Partnership Development Committee
-
FOI/2023/0641 - Diversity and equality; Stonewall Diversity Champions, Stonewall Workplace Equality, NHS Rainbow Badge schemes
-
FOI/2023/0648 - Robotic Process Automation (RPA)
-
FOI/2023/0655 - Customer Relationship Management (CRM) system
-
FOI/2023/0657 - Doctors industrial action locum/ agency spend
-
FOI/2023/0667 - Training in informed consent for doctors
-
FOI/2023/0670 - Treatment with immunomodulatory medications